Journal of Pharmacological Sciences · 2011 · 24 citations · 41 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeurodegenerationNeuropharmacologyAntioxidant DefenseNeuroinflammationNeuroprotectionNeurotoxic InjuryNeurotoxic MechanismsNeurotoxicity MechanismsNeuroprotective AgentsNeuroprotective Signaling
Guttiferone-A (GA) is a natural occurring polyisoprenylated benzophenone with several reported pharmacological actions. We have assessed the protective action of GA on iron-induced neuronal cell damage by employing the PC12 cell line and primary culture of rat cortical neurons (PCRCN). A strong protection by GA, assessed by the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carbox-anilide (XTT) assay, was revealed, with IC(50) values <1 µM. GA also inhibited Fe(3+)-ascorbate reduction, iron-induced oxidative degradation of 2-deoxiribose, and iron-induced lipid peroxidation in rat brain homogenate, as well as stimulated oxygen consumption by Fe(2+) autoxidation. Absorption spectra and cyclic voltammograms of GA-Fe(2+)/Fe(3+) complexes suggest the formation of a transient charge transfer complex between Fe(2+) and GA, accelerating Fe(2+) oxidation. The more stable Fe(3+) complex with GA would be unable to participate in Fenton-Haber Weiss-type reactions and the propagation phase of lipid peroxidation. The results show a potential of GA against neuronal diseases associated with iron-induced oxidative stress.
41
Kenjiro Ono, Yuji Yoshiike, Akihiko Takashima et al. · Journal of Neurochemistry · 2003 · 683 citations
Yona Levites, Tamar Amit, Silvia Mandel et al. · The FASEB Journal · 2003 · 375 citations